ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 293

Usefulness of Cardiac Magnetic Resonance in the Assessment of Myocardial Inflammation and Fibrosis in Children Born to Mothers with Anti-SSA/Ro Antibodies: A Prospective Study of 23 Cases and 6 Controls

Nathalie Costedoat-Chalumeau1, Alice Maltret2, Kateri Levesque1, Shelby Kutty3, Elisabeth Villain2, Phalla Ou4 and Gaëlle Guettrot-Imbert5, 1Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, 2Cardiology, Groupe Hospitalier Necker - Enfants Malades, Paris, France, 3Division of Pediatric Cardiology, university of Nebraska Medical Center and Children's Hospital ans Medical Center, Omaha, NE, USA, Omaha, 4Radiology,, Groupe Hospitalier Necker - Enfants Malades, Paris, France, 5Internal Medicine, Hopital Gabriel Montpied, Clermont-Ferrand, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), neonatal disorders and systemic lupus erythematosus (SLE), Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Besides congenital heart blocks (CHB), others manifestations of cardiac neonatal lupus erythematosus syndrome (NLES) include endocardial fibroelastosis (EFE), and dilated cardiomyopathy. Recently, autopsy of fetuses and children with cardiac NLES showed that EFE was under-diagnosed by echocardiography. We investigated the utility of cardiac magnetic resonance (CMR) for myocardial characterization, in children exposed in uteroto anti-SSA/Ro antibodies (Ab), with focus on inflammation and fibrosis.

Methods: Children born to mothers with anti-SSA/Ro Ab were enrolled in a prospective study performed from December 2011 to June 2012. The control group consisted of 6 healthy children born to mothers without anti-SSA Ab. All the children had a complete cardiac testing with electrocardiogram, echocardiography and a CMR assessments (T2-weighted sequence for myocardial edema, T1-weighted sequence before and after intravenous administration of gadolinium for hyperemia, and late gadolinium enhancement). Positive findings in 2 of 3 sequences were considered diagnostic of myocarditis, and positive late gadolinium enhancement indicative of fibrosis.

Results: 23 children with (n=15, group 1) and without (n=8, group 2) cardiac NLES were included. Cardiac manifestations in group 1 were complete CHB (n=10), 2nd degree CHB (n=2), 1st degree CHB (n=1), supraventricular tachycardia (n=2). EFE was present on the in utero echocardiography in 7.

Group 2 included 3 children with cutaneous manifestations of NLES, and 5 symptom free children (2 had siblings with NLES manifestations).

11 children (10 in group 1 and 1 in group 2) had abnormal CMR whereas only 3 (all in group 1) had abnormal postnatal echocardiography (table1). Interestingly, no myocardial inflammation was observed after 3 months of life. The 6 children of the control group (anti-SSA-) had normal CMR.

CMR was performed twice in 3 children (2 with CHB and 1 with supraventricular tachycardia and EFE). In 2 children, the second MRI showed stability or an improvement of inflammation after 5 and 11 days respectively. In the third child (with CHB), an extension of fibrosis was observed after 9 months. This child died of heart failure at 2.8 years old despite cardiac pacing.

Conclusion: CMR is more sensitive than echocardiography to show myocarditis and/or fibrosis associated to anti-SSA antibodies. Further studies are needed to correlate CMR characteristics with late onset dilated cardiomyopathy.

 

 

Normal CMR

Normal but incomplete CMR (without injection)

Inflammation

Inflammation and fibrosis

Fibrosis

Children

11

2

2

2

6

Median age of children at CMR (years)

1.75 [0.01-8.54]

0.93

0.17

0.14

2.14 [0.01- 7.6]

Number of children

 

 

 

 

 

–          group 1 (SSA+, cardiac NLES)

4

2

2

1

6

–          group 2 (SSA+, no cardiac NLES)

7

 

 

1

 

In utero echocardiography

 

 

 

 

 

– normal

11

1

 

1

2

– EFE

 

1

2

1

3

– Not available

 

 

 

 

1

Post natal echocardiography

 

 

 

 

 

– normal

11

2

1

1

5

– EFE

 

 

1

1

1


Disclosure:

N. Costedoat-Chalumeau,
None;

A. Maltret,
None;

K. Levesque,
None;

S. Kutty,
None;

E. Villain,
None;

P. Ou,
None;

G. Guettrot-Imbert,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usefulness-of-cardiac-magnetic-resonance-in-the-assessment-of-myocardial-inflammation-and-fibrosis-in-children-born-to-mothers-with-anti-ssaro-antibodies-a-prospective-study-of-23-cases-and-6-contro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology